Natalya Davies
Stock Analyst at Roth Capital
(1.09)
# 3,866
Out of 5,241 analysts
4
Total ratings
50%
Success rate
-7.43%
Average return
Main Sectors:
Stocks Rated by Natalya Davies
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGEN Repligen | Initiates: Buy | $160 | $104.20 | +53.55% | 1 | Apr 17, 2026 | |
| BRKR Bruker | Initiates: Buy | $60 | $42.75 | +40.35% | 1 | Nov 20, 2025 | |
| WAT Waters | Initiates: Buy | $390 | $332.19 | +17.40% | 1 | Oct 8, 2025 | |
| A Agilent Technologies | Initiates: Buy | $165 | $112.11 | +47.18% | 1 | Oct 8, 2025 |
Repligen
Apr 17, 2026
Initiates: Buy
Price Target: $160
Current: $104.20
Upside: +53.55%
Bruker
Nov 20, 2025
Initiates: Buy
Price Target: $60
Current: $42.75
Upside: +40.35%
Waters
Oct 8, 2025
Initiates: Buy
Price Target: $390
Current: $332.19
Upside: +17.40%
Agilent Technologies
Oct 8, 2025
Initiates: Buy
Price Target: $165
Current: $112.11
Upside: +47.18%